Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 2008

View Archived Issues

Labopharm reports positive results for phase III trazodone study

e-STAR data show risperidone long-acting injection beneficial in schizophrenia

Add-on pimavanserin improves efficacy and safety of risperidone in schizophrenia

Cervical cancer vaccine safe, immunogenic in stage IB and IIA patients

Pro-Pharmaceuticals reports encouraging data from phase II trial of Davanat in colorectal cancer

Blood pressure control safely achieved with clevidipine in high risk patients

AstraZeneca submits application for Seroquel and Seroquel XR in the E.U.

Keryx Biopharmaceuticals completes phase III clinical trial of Sulonex

La Jolla Pharmaceutical presents an update on the phase III trial of Riquent for SLE

Recent patents impart novel treatment options for cancer

Washington University investigators study role of moss protein in Alzheimer's disease

Targanta submits NDA to FDA for oritavancin

Preliminary clinical data show significant HIV viral load reduction with IDX-899

Silodosin NDA accepted for filing by FDA for benign prostatic hyperplasia

Biovitrum completes exploratory phase II study of BVT-28949 in glaucoma

Positive efficacy data reported from phase II Gabapentin GR trial

SCH-532706 safe and well tolerated in combination with ritonavir

Valeant reports positive phase III results for retigabine in RESTORE 1

Decapeptyl 6-month formulation shows similar efficacy to 3-month triptorelin

Study shows self-applied diarrhea vaccine patch has robust immune response

Recent Merck patents describe novel agents for sleep disorders

Recent Allergan patents disclose new therapeutics for glaucoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...